November 7, 2023
Press
New Paper: Investigating the effects of Olaparib on the susceptibility of Glioblastoma
In this paper, Moran et al. examined the potential of Olaparib in combination with natural killer cell therapies in glioblastoma multiforme, a highly invasive and aggressive primary brain malignancy.
Our cellQART 5 micron pore size inserts were used to assess the effects of Olaparib on natural killer cell chemotaxis towards T98G cells.
Source: Moran, J. et al. Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses. Pharmaceutics 15, 360 (2023).
